DONATE
  • Home
  • About Us
    • Executive Committee
    • About MS Australia
    • Links
  • For People with MS
    • What are Clinical Trials?
    • Find a MS trial
    • MS Glossary
  • For Research Professionals
  • For Trial Sponsors
  • News
  • Contact Us
DONATE
Increasing awareness, participation, funding and streamlining communication for MS trials
  • Home
  • About Us
    • Executive Committee
    • About MS Australia
    • Links
  • For People with MS
    • What are Clinical Trials?
    • Find a MS trial
    • MS Glossary
  • For Research Professionals
  • For Trial Sponsors
  • News
  • Contact Us
0
By Tennille Luker
In ACT, NSW, NT, QLD, SA, TAS, VIC, WA
Posted June 23, 2022

Crisis Resilience in MS; considering experience of persons with MS to improve crisis and disaster management

READ MORE
0
By Tennille Luker
In QLD, VIC
Posted June 21, 2022

An early feasibility study of the safety of an endovascular Motor Neuroprosthesis (MNP) in participants with severe upper limb dysfunction

READ MORE
0
By Tennille Luker
In NSW
Posted June 21, 2022

Functional electrical stimulation cycling combined with arm cranking for improving aerobic fitness for people with advanced MS

READ MORE
0
By Tennille Luker
In ACT, NSW, NT, QLD, SA, TAS, VIC, WA
Posted June 16, 2022

The Wellbeing Neuro Course: A Randomised Controlled Trial of an Online Treatment Program for Adults with Multiple Sclerosis

READ MORE
0
By Tennille Luker
In NSW, QLD, VIC
Posted June 7, 2022

A Study To Evaluate The Efficacy And Safety Of Fenebrutinib Compared With Ocrelizumab In Adult Participants With Primary Progressive Multiple Sclerosis (FENtrepid)

READ MORE
0
By Tennille Luker
In QLD
Posted June 1, 2022

Reducing the frequency of Autoimmune adverse events in the treatment of Multiple sclerosis with alemtuzumab using B-celL dEpletion (RAMBLE): a phase II, randomised, placebo-controlled clinical trial

READ MORE
0
By Tennille Luker
In NSW, QLD, VIC, WA
Posted May 31, 2022

An Open-label Study Evaluating Ofatumumab Treatment Effectiveness and PROs in Subjects With RMS Transitioning From Fumarate-based RMS Approved Therapies or Fingolimod to Ofatumumab (ARTIOS)

READ MORE
0
By Tennille Luker
In ACT, NSW, NT, NZ, QLD, SA, TAS, VIC, WA
Posted May 30, 2022

Cellular Horizons: Improving decisions about access to stem cell interventions

READ MORE
0
By Tennille Luker
In SA
Posted May 25, 2022

An investigation of a novel mechanism of obstructive sleep apnoea (OSA) in people with Multiple Sclerosis (MS)

READ MORE
0
By Tennille Luker
In ACT, NSW, NT, NZ, QLD, SA, TAS, VIC, WA
Posted May 20, 2022

Online surveys: Pregnant women with Multiple Sclerosis & another long-term physical/mental health condition

READ MORE
1 2 3 4 5
page 1 of 5

1300 010 158mstrials@msaustralia.org.au

SUBSCRIBE TO OUR NEWSLETTER

DONATE

Quick Links
  • Find a MS trial
  • People with MS
  • MS Glossary
  • Health Professionals
  • Trial Sponsors
  • MS Australia
  • MS Australia Brain Bank
  • Australian MS Longitudinal Study
© 2022 Multiple Sclerosis Australia | ABN: 51 008 515 508 │ Privacy policy │ Whistleblower Policy │ Terms and conditions │ Managed by Wolf IQ
Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search

Subscribe to our newsletter

  • Enter your details: